|
|
|
| Economic evaluation of free newborn screening for congenital heart disease in Lishui City |
| YIN Chang1, YE Jiajia2, YANG Yongmei1
|
1. School of Medical Humanities and Management, Wenzhou Medical University, Wenzhou, Zhejiang 325025, China;
2. Lishui Maternal and Child Health Care Hospital, Lishui, Zhejiang 323000, China |
|
|
|
|
Abstract Objective To evaluate the health economic value of the free screening policy for congenital heart disease (CHD) among newborns in Lishui City, Zhejiang Province, so as to provide the evidence for optimizing health resource allocation and improving basic public health services. Methods Data on free CHD screening in Lishui City from 2022 to 2024 were collected through the Newborn CHD Screening Registration System of Lishui Maternity and Child Health Care Hospital. With no screening as the control, costs, benefits and utilities were calculated and discounted to the year 2022 at a discount rate of 3%. Benefit-cost ratio (BCR) and incremental cost-utility ratio (ICUR) were used for economic evaluation. One-way sensitivity analysis and Monte Carlo probabilistic sensitivity analysis were conducte. Results A total of 44 343 newborns were screened for free CHD in Lishui City from 2022 to 2024. Among them, 4 202 tested positive on initial screening, 367 were confirmed as CHD cases, and 3 835 were false-positive. After discounting, the total screening cost was 2.141 0 million yuan, with total benefits of 13.148 2 million yuan and the net health utility gain was 245.32 quality-adjusted life year (QALY). The BCR was 6.14, and the ICUR was 8 727 yuan/QALY, which was lower than the willingness-to-pay threshold of per capita gross domestic product in Lishui City (78 978 yuan/QALY). Sensitivity analysis showed that the BCR remained above 1 and the ICUR remained below the willingness-to-pay threshold across all key parameters, indicating robust results. Conclusions The free newborn CHD screening policy in Lishui City presents favorable economic efficiency and scalability. It is recommended to further optimize costs and benefits through centralized procurement of consumables and closed-loop information management.
|
|
Received: 09 January 2026
Revised: 17 March 2026
Published: 22 June 2026
|
|
|
|
|
|
[1] HOFFMAN J I E,KAPLAN S.The incidence of congenital heart disease[J].J Am Coll Cardiol,2002,39(12):1890-1900.
[2] KEMPER A R,MAHLE W T,MARTIN G R,et al.Outcome of pulse oximetry screening for critical congenital heart disease[J].N Engl J Med,2011,364(16):1599-1608.
[3] 胡晓静,马晓静,曾子倩,等.应用脉搏血氧饱和度或/和临床评估(心脏杂音听诊)筛查新生儿危重型先天性心脏病的系统评价和Meta分析[J].中国循证儿科杂志,2020,15(5):325-332.
[4] 陆天玮,胡晓静,张崇凡,等.新生儿危重症先天性心脏病筛查的卫生经济学系统评价[J].中国循证儿科杂志,2022,17(3):195-201.
[5] PETERSON C,DAWSON A,GROSSE S D,et al.Hospitalizations,costs,and mortality among infants with critical congenital heart disease:how important is timely detection[J].Birth Defects Res A Clin Mol Teratol,2013,97(10):664-672.
[6] ABOUK R,GROSSE S D,AILES E C,et al.Association of US state implementation of newborn screening policies for critical congenital heart disease with early infant cardiac deaths[J].JAMA,2017,318(21):2111-2118.
[7] 那艺诺,李艺,王丹,等.基于支付意愿法中国统计生命价值系统评价[J].中国公共卫生,2025,41(2):239-245.
[8] 顾学范,王家军,叶军,等.筛查新生儿苯丙酮尿症和先天性甲状腺机能减低症的成本效益分析[J].中华预防医学杂志,2000,34(3):20-22.
[9] BRIGGS A H,WEINSTEIN M C,FENWICK E A,et al.Model parameter estimation and uncertainty analysis:a report of the ISPOR-SMDM modeling good research practices task force working group-6[J].Med Decis Making,2012,32(5):722-732.
[10] REEDER M R,KIM J,NANCE A,et al.Evaluating cost and resource use associated with pulse oximetry screening for critical congenital heart disease:empiric estimates and sources of variation[J].Birth Defects Res A Clin Mol Teratol,2015,103(11):962-971.
[11] MUKERJI A,SHAFEY A,JAIN A,et al.Pulse oximetry screening for critical congenital heart defects in Ontario,Canada:a cost-effectiveness analysis[J].Rev Can De Sante Publique,2020,111(5):804-811.
[12] PETERSON C,GROSSE S D,OSTER M E,et al.Cost-effectiveness of routine screening for critical congenital heart disease in US newborns[J].Pediatrics,2013,132(3):595-603.
[13] EWER A K,FURMSTON A T,MIDDLETON L J,et al.Pulse oximetry as a screening test for congenital heart defects in newborn infants:a test accuracy study with evaluation of acceptability and cost-effectiveness[J].Health Technol Assess,2012,16(2):1-184.
[14] LONDOÑO TRUJILLO D,SANDOVAL REYES N F,TABORDA RESTREPO A,et al.Cost-effectiveness analysis of newborn pulse oximetry screening to detect critical congenital heart disease in Colombia[J/OL].Cost Eff Resour Alloc,2019,17[2026-03-17].http://doi.org/10.1186/s12962-019-0179-2.
[15] 丽扎·江阿别克,阿扎玛提·阿扎提,马荣,等.先天性心脏病患儿家庭经济负担及影响因素分析[J].中国卫生经济,2024,43(2):62-66. |
|
|
|
